Locations:
Search
Psychosocial oncology offers a path forward
A conversation with Marcelo Pasquini, MD
International study supports change in clinical care in post-neoadjuvant setting
Preliminary results suggest combination therapy with lisaftoclax improves survival with few adverse events in patients with AL amyloidosis and relapsed/refractory multiple myeloma
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
New system refines classification of cytogenetic abnormalities at time of response assessment and their clinical significance
Lifetime Achievement award-winner reflects on psychosocial support and caregiver readiness
Questions remain about the merits of asparaginase-based therapy
Phase 1 study found mutant calreticulin-specific monoclonal antibody brings promising results with no dose-limiting toxicities
Cleveland Clinic psychiatrist urges integrating psychosocial care into oncology
A retrospective analysis
Advertisement
Advertisement